Midland Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Sell
13,532
-833
-6% -$21.8K 0.02% 136
2026
Q1
$403K Sell
14,365
-949
-6% -$25.3K 0.02% 119
2025
Q4
$381K Sell
15,314
-2,850
-16% -$71.9K 0.02% 123
2025
Q3
$463K Sell
18,164
-4,639
-20% -$115K 0.02% 119
2025
Q2
$553K Sell
22,803
-3,461
-13% -$80.7K 0.03% 114
2025
Q1
$666K Sell
26,264
-3,044
-10% -$79.7K 0.04% 107
2024
Q4
$778K Sell
29,308
-3,943
-12% -$107K 0.05% 99
2024
Q3
$962K Sell
33,251
-6,554
-16% -$191K 0.06% 91
2024
Q2
$1.11M Sell
39,805
-1,393
-3% -$38.4K 0.07% 81
2024
Q1
$1.14M Sell
41,198
-11,091
-21% -$308K 0.07% 80
2023
Q4
$1.51M Buy
+52,289
New +$1.58M 0.1% 57

Other funds holding PFE

Midland Wealth Advisors's PFE Position: Q2 2026 in Review

Midland Wealth Advisors reduced its Pfizer (PFE) stake by 5.8% in Q2 2026, selling an estimated $21.8K and leaving 13,532 shares worth $326K. The position accounts for 0.02% of the portfolio, ranked #136.

Midland Wealth Advisors first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.51M in Q4 2023. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Midland Wealth Advisors held 13,532 shares of Pfizer worth $326K as of Q2 2026.
  • Midland Wealth Advisors sold 833 Pfizer shares in Q2 2026, an estimated $21.8K.
  • Pfizer made up 0.02% of Midland Wealth Advisors's portfolio in Q2 2026, its #136 holding.
  • Midland Wealth Advisors first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Midland Wealth Advisors's Pfizer position peaked at $1.51M in Q4 2023.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Midland Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.